The spectrum of opportunistic infections and malignancies among women on antiretroviral therapy in Ethiopia

Yimam Getaneh; Fentabil Getnet; Abdur Rashid; Li Kang; Qingfei Chu; Sisi Li; Feng Yi; Yiming Shao

doi:10.1080/22221751.2023.2271065

The spectrum of opportunistic infections and malignancies among women on antiretroviral therapy in Ethiopia

Emerg Microbes Infect. 2023 Dec;12(2):2271065. doi: 10.1080/22221751.2023.2271065. Epub 2023 Oct 27.

Authors

Yimam Getaneh^{1

2}, Fentabil Getnet^{2

3

4}, Abdur Rashid^{5

6}, Li Kang^{5

6}, Qingfei Chu¹, Sisi Li⁶, Feng Yi⁶, Yiming Shao^{1

6}

Affiliations

¹ State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, People's Republic of China.
² Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
³ Takemi Program in International Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
⁴ T.H. Chan School of Public Health, Boston, MA, USA.
⁵ School of Medicine, Nankai University, Tianjin, People's Republic of China.
⁶ State Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.

Abstract

AIDS: acquired immune deficiency syndrome; CI: confidence interval; EPHI: Ethiopian Public Health Institute; HAART: highly active antiretroviral therapy; HIV: human immunodeficiency virus; HR: hazard ratio; Mg/dl: milligram per deciliter; TB: tuberculosis; PCP: pneumocystis carinii pneumonia; ZJU: Zhejiang University.

Keywords: HIV/AIDS; Incidence; malignancy; mortality; opportunistic infections.

MeSH terms

AIDS-Related Opportunistic Infections* / epidemiology
Acquired Immunodeficiency Syndrome* / drug therapy
Antiretroviral Therapy, Highly Active
Ethiopia / epidemiology
Female
HIV Infections* / complications
HIV Infections* / drug therapy
HIV Infections* / epidemiology
Humans
Neoplasms*